BGI, H3 Biomedicine Strike Sequencing Data Publishing Pact | GenomeWeb

NEW YORK (GenomeWeb News) – BGI and H3 Biomedicine today announced they will sequence and publish data from next-generation sequencing-based research on pre-clinical cancer models.

In the first study to be performed under the terms of the partnership, BGI will sequence 250 cancer cell lines using next-generation whole-exome sequencing. It and H3 Biomedicine will jointly analyze the data and then deliver a highly curated set of "genetically profiled, pre-clinical model information that will help to accelerate drug discovery and development efforts."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.